Publication date
January 2008
DOI Publisher
Family Physicians Inquiries Network ISSN
1553-3271 Language
EnglishAbstract
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of myasthenia gravis
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of myasthenia gravis
Myasthenia gravis is an autoimmune disorder that places patients in debilitating condition. It curre...
Introduction and purpose: Myasthenia gravis (MG, myasthenia gravis ) is a classic example of an auto...
Myasdienia gravis (MG) is an antibody-mediated autoimmune disease causing muscle weakness and fatigu...
Abstract Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary ...
Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder. Circulating autoantibodie...
Myasthenia gravis (MG) is an autoimmune disease characterised by autoantibodies against acetylcholin...
Myasthenia gravis is a neuro-muscular junction disorder characterized by skeletal muscle weakness an...
Introduction: Myasthenia gravis (MG) is the most common acquired autoimmune disorder of neuromuscula...
Myasthenic crisis is a condition characterized by the sudden onset of myasthenic weakness involving ...
ABSTRACT The clinical history and neurological examination provide the most important data on which ...
The distribution of muscle weakness in MG is highly heterogeneous and frequently shifts in patients....
Acquired myasthenia gravis is a relatively uncommon disorder, with prevalence rates that have increa...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscl...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction that can deteriorate into myasthe...
Myasthenia gravis is an autoimmune disorder that places patients in debilitating condition. It curre...
Introduction and purpose: Myasthenia gravis (MG, myasthenia gravis ) is a classic example of an auto...
Myasdienia gravis (MG) is an antibody-mediated autoimmune disease causing muscle weakness and fatigu...
Abstract Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary ...
Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder. Circulating autoantibodie...
Myasthenia gravis (MG) is an autoimmune disease characterised by autoantibodies against acetylcholin...
Myasthenia gravis is a neuro-muscular junction disorder characterized by skeletal muscle weakness an...
Introduction: Myasthenia gravis (MG) is the most common acquired autoimmune disorder of neuromuscula...
Myasthenic crisis is a condition characterized by the sudden onset of myasthenic weakness involving ...
ABSTRACT The clinical history and neurological examination provide the most important data on which ...
The distribution of muscle weakness in MG is highly heterogeneous and frequently shifts in patients....
Acquired myasthenia gravis is a relatively uncommon disorder, with prevalence rates that have increa...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscl...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction that can deteriorate into myasthe...
Myasthenia gravis is an autoimmune disorder that places patients in debilitating condition. It curre...
Introduction and purpose: Myasthenia gravis (MG, myasthenia gravis ) is a classic example of an auto...
Myasdienia gravis (MG) is an antibody-mediated autoimmune disease causing muscle weakness and fatigu...
Add to ORKG